Navigation Links
Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook

l succinate extended-release tablets and GlaxoSmithKline's sales of Wellbutrin XLP(R) 150mg.

Generic segment gross margin increased from 30 percent in 2006 to 39 percent in 2007, due to the increase in other revenue, improved product mix and enhanced operational efficiencies.

During 2007, Watson submitted 21 ANDAs with the U.S. Food and Drug Administration (FDA). Watson currently has approximately 60 ANDAs on file with the FDA.

Brand Segment Information

Three Months Ended Twelve Months Ended

December 31, December 31,

(Unaudited; $ in thousands) 2007 2006 2007 2006

Brand Segment Contribution

Product sales $94,106 $97,239 $375,202 $354,070

Other revenue 15,232 9,743 53,520 15,402

Net revenue 109,338 106,982 428,722 369,472

Cost of sales 25,814 27,595 99,913 92,184

Gross profit 83,524 79,387 328,809 277,288

Gross margin 76.4% 74.2% 76.7% 75.0%

Research and development 10,435 14,021 42,367 47,472

Selling and marketing 28,664 27,071 108,061 112,258

Segment contribution $44,425 $38,295 $178,381 $117,558

Segment margin 40.6% 35.8% 41.6% 31.8%

Brand product sales for the fourth quarter of 2007 decreased 3 percent or $3.1 million to $94.1 million, primarily due to lower sales of INFeD(R) and Ferrlecit(R). Other revenue increased $5.5 million to $15.2 million, due to increased revenue from the co-promotion of AndroGel(R) and other promoted products.

Gross margin for the Brand segment increased from 74 percent in the fourth quarter 2006 to 76 percent in

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
2. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
3. Watson Receives FDA Approval for Generic Accuneb(R)
4. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
5. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
6. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
7. Boehringer Ingelheim Pharmaceuticals, Inc. Receives the NCQA Seal Of Approval
8. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. Keryx Biopharmaceuticals Announces Additions to Management Team
11. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
Post Your Comments:
(Date:1/22/2015)... 21, 2015 Cambridge Semantics, the leading provider ... announced that 2014 was a record-breaking year across the board ... the Anzo Smart Data Platform and our Smart Data solutions, ... from diverse data which led to record growth for the ...
(Date:1/22/2015)... Rootstown, OH (PRWEB) January 22, 2015 Crystal ... announced today that it has received AOAC-PTM Certifications for the ... O111, O121, and O145; collectively referred to as STEC or ... at 1 colony forming unit (cfu) per 325 g of ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Dr. Greg Leyer ... 12th annual Scripps Natural Supplements Pre-Conference seminar on probiotics in ... is an annual continuing education conference for health care professionals. ... included the topic of probiotics in health. Dr. Leyer spoke ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 ... technologies such as the Bioruptor® and complete solutions ... system for chromatin immunoprecipitation, alleviating the need for ... and controls needed for ChIP of histones or ...
Breaking Biology Technology:Cambridge Semantics Announces Record Results for 2014 2Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2
... Calif., March 6 Finesse Solutions, LLC, Santa Clara, ... life sciences process applications, announced the technical demonstration of ... at Interphex in New York on March 17, 2009.The ... consisting of a disposable sheath, an optical reader, and ...
... SEATTLE, March 6 Cell Therapeutics, Inc. (CTI) (Nasdaq ... a letter from The NASDAQ Stock Market indicating that ... the listing of the Company,s common stock on The ... or before April 6, 2009, the Company demonstrate compliance ...
... 6 Irvine Scientific, a leading medical device/biopharmaceutical company ... the addition of IS CHO-CD XP(TM) Culture System to ... Culture System is a set of chemically-defined*, serum-free, and ... deliver robust cell growth and production for recombinant CHO ...
Cached Biology Technology:Finesse Demonstrates TruFluor(TM) pH, a Single-Use Optical pH Sensor and Transmitter 2Cell Therapeutics Announces Receipt of NASDAQ Listing Update 2Cell Therapeutics Announces Receipt of NASDAQ Listing Update 3Irvine Scientific Launches IS CHO-CD XP(TM) 2
(Date:12/19/2014)... MOUNTAIN VIEW, Calif. , Dec. 18, 2014  23andMe, Inc., ... a study that pinpoints fine-scale differences in genetic ancestry of ... Since immigrants first arrived more than four hundred ... served as a meeting place for peoples from different continents. ...
(Date:12/17/2014)... 2014 Research and Markets ( ) ... S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis" ... Based on a totally ... for the first time a fingerprint sensor in its ...
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB SM ... (GCP) audit to confirm its adherence to current U.S. ... HITLAB to conduct regulated smart device and smart phone ... and research quality. "HITLAB is determined to ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... The most robust statistical examination to date of our species, ... all living humans -- confirms that she lived about 200,000 ... side-by-side comparison of 10 human genetic models that each aim ... of assumptions about the way humans migrated, expanded and spread ...
... lead to a brand new class of drugs to treat ... back pain without numbing the whole body. The ... (BBSRC) and working at UCL (University College London), have shown ... are regulated by molecules inside cells called small RNAs. This ...
... the best of times, but plants have an extra difficulty. If ... and reproduce, you will want your flowerstalks to be long. That ... But if your stalk is too long, you,ll stand out to ... used to be thought that carnivorous plants like Sundews had the ...
Cached Biology News:Mother of all humans lived 200,000 years ago 2Mother of all humans lived 200,000 years ago 3Scientists uncover Achilles heel of chronic inflammatory pain 2Sundews just want to be loved 2
ChIP-GLAS kit for H10K-B microarray chips. Contains ChIP kit, GLAS kit, and hybridization kit. Additional reagents are required. Please see manual for details. Contains sufficient reagent for 20 reac...
BD BaculoGoldTM Transfection Kit 5 transfections...
Biology Products: